Arcus Biosciences Cash from Financing (TTM) Analysis

Arcus Biosciences Inc (RCUS)

15.56 +0.82 (+5.60%) USD | NYSE | Apr 26, 16:00

15.56 0.00 (0.00%) After-Hours: 19:28

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	33.00M
September 30, 2023	41.00M
June 30, 2023	38.00M
March 31, 2023	19.00M
December 31, 2022	33.00M
September 30, 2022	33.33M
June 30, 2022	31.65M
March 31, 2022	29.88M
December 31, 2021	237.00M
September 30, 2021	227.67M
June 30, 2021	333.87M
March 31, 2021	660.51M
December 31, 2020	439.00M

Date	Value
September 30, 2020	437.52M
June 30, 2020	329.96M
March 31, 2020	1.738M
December 31, 2019	1.123M
September 30, 2019	1.374M
June 30, 2019	1.408M
March 31, 2019	-0.359M
December 31, 2018	129.07M
September 30, 2018	234.90M
June 30, 2018	235.10M
March 31, 2018	236.80M
December 31, 2017	107.40M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.123M

Minimum

Dec 2019

660.51M

Maximum

Mar 2021

154.21M

Average

33.33M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks